Jaguar health receives additional 180-day grace period to regain compliance with nasdaq's bid price rule

San francisco, ca / accesswire / november 8, 2023 / jaguar health, inc. (nasdaq:jagx) ("jaguar" or the "company") today announced that on november 8, 2023 the company received formal notice that the listing qualifications staff (the "staff") of the nasdaq stock market llc has granted jaguar an additional 180-day grace period, through may 6, 2024, to regain compliance with the $1.00 bid price requirement for continued listing on the nasdaq capital market. the staff noted that the company meets all other applicable requirements for initial and continued listing on the nasdaq capital market.
JAGX Ratings Summary
JAGX Quant Ranking